The historical rank and industry rank for Sunesis Pharmaceuticals's Net Margin % or its related term are showing as below:
SNSS's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -162.84 * Ranked among companies with meaningful Net Margin % only.
Sunesis Pharmaceuticals Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sunesis Pharmaceuticals's Net Margin %
For the Biotechnology subindustry, Sunesis Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunesis Pharmaceuticals's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunesis Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sunesis Pharmaceuticals's Net Margin % falls into.
Sunesis Pharmaceuticals Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Sunesis Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunesis Pharmaceuticals (NAS:SNSS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sunesis Pharmaceuticals Net Margin % Related Terms
Thank you for viewing the detailed overview of Sunesis Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sunesis Pharmaceuticals (Sunesis Pharmaceuticals) Business Description
Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNSS has been successfully added to your 